Microenvironmental Self‐Optimizing HOFs Biocatalysts for Boosting Disulfidptosis‐Mediated Antitumor Immunotherapy
Authors:
- 29 August 2025
- journal article
- Published by Wiley in Advanced Functional Materials
- Vol. 36 (10)
Abstract
Disulfidptosis, a novel programmed cell death mechanism triggered by glucose deprivation in solute carrier family 7 member 11 (SLC7A11)‐overexpressing tumors, facilitates the release of tumor‐associated antigens (TAAs) and activates immune responses, providing a new strategy to enhance immunotherapy by converting redox vulnerabilities into immunogenic opportunities. Herein, a hydrogen‐bonded organic frameworks (HOFs)‐based cascade biocatalyst is constructed to boost disulfidptosis‐mediated antitumor immunotherapy. Engineered via charge‐mediated assembly, peroxidase‐mimetic iron‐porphyrin HOFs are integrated with glucose oxidase (GOx) to establish a microenvironmental self‐optimizing catalytic network. The HOFs architecture not only enhances GOx stability but also converts enzymatically generated H 2 O 2 into cytotoxic hydroxyl radicals. Simultaneously, GOx‐mediated glucose depletion acidifies the catalytic cavity microenvironment within HOFs, thereby amplifying catalytic efficiency. This biocatalysis system disrupts redox homeostasis, induces glucose deprivation, and activates disulfidptosis. By coupling immunogenic antigen release with oxidative damage, the platform transforms redox vulnerabilities into immune‐activating signals, effectively converting “cold” tumors into immunologically active states. This molecularly engineered approach pioneers the construction strategy of cavity self‐acidized HOFs‐based biocatalysts that harmonize divergent catalytic conditions, enabling cross‐scale biocatalysis, and offers a paradigm shift in cancer immunotherapy by integrating metabolic intervention, immunogenic cell death, and microenvironment remodeling into a unified therapeutic strategy.Keywords
Funding Information
- National Natural Science Foundation of China (22407021)
- National Natural Science Foundation of China (32471452)
- National Natural Science Foundation of China (52333011)
- National Natural Science Foundation of China (U24A20763)
- Natural Science Foundation of Chongqing Municipality (CSTB2023NSCQ‐MSX0493)
- Natural Science Foundation of Chongqing Municipality (cstc2021jcyj‐cxttX0002)
This publication has 49 references indexed in Scilit:
- Fe/Mo‐Based Lipid Peroxidation Nanoamplifier Combined with Adenosine Immunometabolism Regulation to Augment Anti‐Breast Cancer ImmunityAdvanced Materials, 2025
- Inhibition of Endoplasmic Reticulum Stress Cooperates with SLC7A11 to Promote Disulfidptosis and Suppress Tumor Growth upon Glucose LimitationAdvanced Science, 2024
- Engineering Semiconducting Polymeric Nanoagonists Potentiate cGAS‐STING Pathway Activation and Elicit Long Term Memory Against Recurrence in Breast CancerAdvanced Materials, 2024
- Open‐Source Throttling of CD8 + T Cells in Brain with Low‐Intensity Focused Ultrasound‐Guided Sequential Delivery of CXCL10, IL‐2, and aPD‐L1 for Glioblastoma ImmunotherapyAdvanced Materials, 2024
- Digitonin‐Loaded Nanoscale Metal–Organic Framework for Mitochondria‐Targeted Radiotherapy‐Radiodynamic Therapy and DisulfidptosisAdvanced Materials, 2024
- A Comprehensive Strategy Based on High Clinical Translational Nanosystem for Programmable Immunotherapy of Triple Negative Breast CancerAdvanced Materials, 2024
- Schottky Heterojunction Realizes In Situ Vaccine‐Like Antitumor Efficacy and Microenvironment Remodeling Upon Near‐Infrared Laser Response in Cold TumorsAdvanced Functional Materials, 2023
- Manganese‐Based Tumor ImmunotherapyAdvanced Materials, 2023
- Pore‐Environment‐Dependent Photoresponsive Oxidase‐Like Activity in Hydrogen‐Bonded Organic FrameworksAngewandte Chemie International Edition, 2023
- A Microenvironment Dual‐Responsive Nano‐Drug Equipped with PD‐L1 Blocking Peptide Triggers Immunogenic Pyroptosis for Prostate Cancer Self‐Synergistic ImmunotherapyAdvanced Functional Materials, 2023